Zentiva Pharma competitive analysis

Latest publications and patents of Zentiva Pharma New

Explore the latest publications and patents granted to Zentiva Pharma, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Zentiva Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Combination Therapy For The Treatment Of Ovarian CancerF HOFFMANN LA ROCHEAug 28, 2024
Rapamycin Derivative For The Treatment Of A Solid Tumor Associated With Deregulated AngiogenesisNOVARTISSep 16, 2019

Latest PTAB cases involving Zentiva Pharma

Discover the latest PTAB cases involving Zentiva Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Zentiva Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ZENTIVA PHARMA2 - - - Highly Aggressive
F HOFFMANN LA ROCHE16140 - - Defensive
NOVARTIS6406 - 21Defensive